ciprofloxacin has been researched along with Mucositis in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigate ciprofloxacin pharmacokinetics after oral administration in patients with haematological malignancies and explore the impact of GI-mucositis on oral bioavailability and clearance in order to assure adequate systemic exposure." | 8.12 | Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies. ( Blijlevens, NMA; Bruggemann, RJM; de Vroom, SL; Geerlings, SE; Knibbe, CAJ; Mathôt, RAA; Molendijk, E; Tonino, SH; van der Linden, PD; van Hest, RM; van Rhee, KP, 2022) |
| "We investigate ciprofloxacin pharmacokinetics after oral administration in patients with haematological malignancies and explore the impact of GI-mucositis on oral bioavailability and clearance in order to assure adequate systemic exposure." | 4.12 | Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies. ( Blijlevens, NMA; Bruggemann, RJM; de Vroom, SL; Geerlings, SE; Knibbe, CAJ; Mathôt, RAA; Molendijk, E; Tonino, SH; van der Linden, PD; van Hest, RM; van Rhee, KP, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Rhee, KP | 1 |
| de Vroom, SL | 1 |
| van Hest, RM | 1 |
| van der Linden, PD | 1 |
| Tonino, SH | 1 |
| Molendijk, E | 1 |
| Mathôt, RAA | 1 |
| Blijlevens, NMA | 1 |
| Knibbe, CAJ | 1 |
| Bruggemann, RJM | 1 |
| Geerlings, SE | 1 |
| Märtson, AG | 1 |
| da Silva Ferreira, AR | 1 |
| Veringa, A | 1 |
| Liu, L | 1 |
| Wardill, HR | 1 |
| Junier, LAT | 1 |
| van der Werf, TS | 1 |
| Harmsen, HJM | 1 |
| Sturkenboom, MGG | 1 |
| Span, LF | 1 |
| Tissing, WJE | 1 |
| Alffenaar, JC | 1 |
| Pohlen, M | 1 |
| Marx, J | 1 |
| Mellmann, A | 1 |
| Becker, K | 1 |
| Mesters, RM | 1 |
| Mikesch, JH | 1 |
| Schliemann, C | 1 |
| Lenz, G | 1 |
| Müller-Tidow, C | 1 |
| Büchner, T | 1 |
| Krug, U | 1 |
| Stelljes, M | 1 |
| Karch, H | 1 |
| Peters, G | 1 |
| Gerth, HU | 1 |
| Görlich, D | 1 |
| Berdel, WE | 1 |
| Jarfaut, A | 1 |
| Santucci, R | 1 |
| Levêque, D | 1 |
| Herbrecht, R | 1 |
4 other studies available for ciprofloxacin and Mucositis
| Article | Year |
|---|---|
Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies.
Topics: Administration, Oral; Adult; Biological Availability; Ciprofloxacin; Citrulline; Hematologic Neoplas | 2022 |
Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study.
Topics: Anti-Infective Agents; Ciprofloxacin; Citrulline; Fluconazole; Follow-Up Studies; Gastrointestinal M | 2023 |
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineopl | 2016 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Ant | 2013 |